HK24186A - Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen,antibody,method of preparation of this antibody,diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody - Google Patents

Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen,antibody,method of preparation of this antibody,diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody

Info

Publication number
HK24186A
HK24186A HK241/86A HK24186A HK24186A HK 24186 A HK24186 A HK 24186A HK 241/86 A HK241/86 A HK 241/86A HK 24186 A HK24186 A HK 24186A HK 24186 A HK24186 A HK 24186A
Authority
HK
Hong Kong
Prior art keywords
antibody
diagnostic
cell line
therapeutic uses
preparation
Prior art date
Application number
HK241/86A
Other languages
English (en)
Inventor
Patrick Chung-Shu Kung
Gideon Goldstein
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22277970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK24186(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of HK24186A publication Critical patent/HK24186A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2881—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD71
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hybrid Cells (AREA)
HK241/86A 1979-12-04 1986-04-03 Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen,antibody,method of preparation of this antibody,diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody HK24186A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/100,071 US4364934A (en) 1979-12-04 1979-12-04 Monoclonal antibody to a human early thymocyte antigen and methods for preparing same

Publications (1)

Publication Number Publication Date
HK24186A true HK24186A (en) 1986-04-11

Family

ID=22277970

Family Applications (1)

Application Number Title Priority Date Filing Date
HK241/86A HK24186A (en) 1979-12-04 1986-04-03 Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen,antibody,method of preparation of this antibody,diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody

Country Status (20)

Country Link
US (1) US4364934A (fr)
EP (1) EP0030814B1 (fr)
JP (2) JPS5695122A (fr)
AT (1) ATE13693T1 (fr)
AU (1) AU545181B2 (fr)
CA (1) CA1175367A (fr)
DE (2) DE3070745D1 (fr)
DK (1) DK153891C (fr)
ES (1) ES497424A0 (fr)
FI (1) FI75599C (fr)
HK (1) HK24186A (fr)
IE (1) IE50724B1 (fr)
IL (1) IL61621A (fr)
MY (1) MY8600518A (fr)
NO (1) NO159887C (fr)
NZ (1) NZ195648A (fr)
PH (1) PH17490A (fr)
PT (1) PT72145B (fr)
YU (1) YU45077B (fr)
ZA (1) ZA807562B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624925A (en) * 1979-12-04 1986-11-25 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods
US4691010A (en) * 1979-12-04 1987-09-01 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen, antibody, and methods
US4434156A (en) 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
JPS60231699A (ja) * 1983-11-09 1985-11-18 Aichiken 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4562003A (en) * 1984-10-26 1985-12-31 California Biotechnology, Inc. Monoclonal antibodies against alveolar surfactant protein
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US5100777A (en) * 1987-04-27 1992-03-31 Tanox Biosystems, Inc. Antibody matrix device and method for evaluating immune status
US5085985A (en) * 1987-11-12 1992-02-04 Becton Dickinson & Co. Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
US5252711A (en) * 1989-06-01 1993-10-12 The Gillette Company Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof
SE503225C2 (sv) * 1991-10-30 1996-04-22 Leif Lindholm Konsult Ab Virus-antikroppskomplex för införing av virus i mammalieceller
BR9610050A (pt) 1995-08-16 1999-10-13 Zeneca Ltd Conjugado,sitemas de dois componentes combinados destinados a uso em um hospedeiro, compostos ou um sal destes famaceuticamente aceitavel,enzima,sequencia de polinucleotìdeos e de02 nucleotìdeos,vetor, célula hospedeira,processos de producão de uma enzima e de um conjugado e de tratamento de célulasneoplásticas em um hospedeiro,composicão farmaceutica e plasmìdeo
EP1034003A4 (fr) * 1997-11-24 2004-07-14 Johnson T Wong Procedes de traitement des infections par le vih ou autres infections utilisant un activateur de lymphocytes t ou un activateur viral et therapie d'association anti-retrovirale
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system
LT3292149T (lt) 2015-05-04 2022-03-10 Cytomx Therapeutics, Inc. Aktyvinami antikūnai prieš cd71 ir jų naudojimo būdai

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses

Also Published As

Publication number Publication date
AU6496180A (en) 1981-06-11
FI75599C (fi) 1988-07-11
ES8301636A1 (es) 1983-01-01
FI803756L (fi) 1981-06-05
NO159887B (no) 1988-11-07
YU306480A (en) 1984-04-30
PT72145B (en) 1982-07-05
ZA807562B (en) 1982-07-28
JPS5695122A (en) 1981-08-01
FI75599B (fi) 1988-03-31
PH17490A (en) 1984-09-04
EP0030814B1 (fr) 1985-06-05
MY8600518A (en) 1986-12-31
US4364934A (en) 1982-12-21
JPH0159869B2 (fr) 1989-12-20
ES497424A0 (es) 1983-01-01
DK153891B (da) 1988-09-19
JPS6363557B2 (fr) 1988-12-07
IE50724B1 (en) 1986-06-25
NO159887C (no) 1989-02-15
JPS6463376A (en) 1989-03-09
DE3070745D1 (en) 1985-07-11
EP0030814A3 (en) 1981-12-30
YU45077B (en) 1992-03-10
CA1175367A (fr) 1984-10-02
DE30814T1 (de) 1984-07-19
AU545181B2 (en) 1985-07-04
IL61621A (en) 1984-07-31
NZ195648A (en) 1984-07-06
ATE13693T1 (de) 1985-06-15
DK153891C (da) 1989-02-20
NO803660L (no) 1981-06-05
PT72145A (en) 1981-01-01
DK517280A (da) 1981-06-05
IE802510L (en) 1981-06-04
EP0030814A2 (fr) 1981-06-24

Similar Documents

Publication Publication Date Title
DE3070655D1 (en) Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses, and pharmaceutical compositions comprising this antibody
DE3070896D1 (en) Monoclonal antibody to human helper t cells, method of preparing it, hybrid cell line producing it, its diagnostic and therapeutic uses and diagnostic and therapeutic compositions comprising it
DE3070744D1 (en) Hybrid cell line for producing complement-fixing, monoclonal antibody to human suppressor t cells, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody
DE3070745D1 (en) Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody
DE3070479D1 (en) Hybrid cell line for producing monoclonal antibody to human thymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody

Legal Events

Date Code Title Description
PE Patent expired